Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity

Clinical trial NCT04954885 · COMPLETED

Trial details

NCT number: NCT04954885
Sponsor: Ohio State University Comprehensive Cancer Center
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Non-Squamous Non-Small Cell Carcinoma Stage IIIB Lung Cancer AJCC v8 Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8

Start date: 2021-05-18
Primary completion: 2022-10-12
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.